Arkolith/Insider Trading/APGE/Form 4

Henderson Jane

Chief Financial OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$140K
Net Open-Market Flow
-$140K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)300$69.43$21K183K
Mar 2, 2026Sell(S)994$70.45$70K182K
Mar 2, 2026Sell(S)300$68.27$20K183K
Mar 2, 2026Sell(S)406$71.66$29K181K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-023651) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML